These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15827142

  • 1. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C, Coan PN, Pandrea I, Grant CK, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [Abstract] [Full Text] [Related]

  • 2. Advances in understanding molecular determinants in FeLV pathology.
    Levy LS.
    Vet Immunol Immunopathol; 2008 May 15; 123(1-2):14-22. PubMed ID: 18289704
    [Abstract] [Full Text] [Related]

  • 3. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C, Coan PN, Levy LS.
    J Virol; 2005 Feb 15; 79(3):1351-60. PubMed ID: 15650161
    [Abstract] [Full Text] [Related]

  • 4. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL, Ahmad S, Lobelle-Rich PA, Ooms TG, Alvarez-Hernandez X, Didier PJ, Levy LS.
    J Virol; 2013 Oct 15; 87(19):10874-83. PubMed ID: 23903838
    [Abstract] [Full Text] [Related]

  • 5. The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome.
    Bolin LL, Ahmad S, Levy LS.
    Vet Immunol Immunopathol; 2011 Oct 15; 143(3-4):221-6. PubMed ID: 21764142
    [Abstract] [Full Text] [Related]

  • 6. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
    Erbeck K, Gagne RB, Kraberger S, Chiu ES, Roelke-Parker M, VandeWoude S.
    J Virol; 2021 Aug 25; 95(18):e0035321. PubMed ID: 34232703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.
    Finstad SL, Prabhu S, Rulli KR, Levy LS.
    Virol J; 2004 Sep 03; 1():3. PubMed ID: 15507152
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
    Athas GB, Choi B, Prabhu S, Lobelle-Rich PA, Levy LS.
    Virology; 1995 Dec 20; 214(2):431-8. PubMed ID: 8553544
    [Abstract] [Full Text] [Related]

  • 12. Genetic diversity in the feline leukemia virus gag gene.
    Kawamura M, Watanabe S, Odahara Y, Nakagawa S, Endo Y, Tsujimoto H, Nishigaki K.
    Virus Res; 2015 Jun 02; 204():74-81. PubMed ID: 25892717
    [Abstract] [Full Text] [Related]

  • 13. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
    Prabhu S, Lobelle-Rich PA, Levy LS.
    Virology; 1999 Oct 25; 263(2):460-70. PubMed ID: 10544118
    [Abstract] [Full Text] [Related]

  • 14. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M, Burns CC, Boomer S, Overbaugh J.
    Virology; 1998 Mar 15; 242(2):366-77. PubMed ID: 9514965
    [Abstract] [Full Text] [Related]

  • 15. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 Jan 15; 79(1):57-66. PubMed ID: 15596801
    [Abstract] [Full Text] [Related]

  • 16. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.
    Pandey R, Bechtel MK, Su Y, Ghosh AK, Hayes KA, Mathes LE, Roy-Burman P.
    Virology; 1995 Dec 20; 214(2):584-92. PubMed ID: 8553560
    [Abstract] [Full Text] [Related]

  • 17. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
    Boomer S, Gasper P, Whalen LR, Overbaugh J.
    Virology; 1994 Nov 01; 204(2):805-10. PubMed ID: 7941350
    [Abstract] [Full Text] [Related]

  • 18. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
    McDougall AS, Terry A, Tzavaras T, Cheney C, Rojko J, Neil JC.
    J Virol; 1994 Apr 01; 68(4):2151-60. PubMed ID: 8138999
    [Abstract] [Full Text] [Related]

  • 19. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
    Brojatsch J, Kristal BS, Viglianti GA, Khiroya R, Hoover EA, Mullins JI.
    Proc Natl Acad Sci U S A; 1992 Sep 15; 89(18):8457-61. PubMed ID: 1326757
    [Abstract] [Full Text] [Related]

  • 20. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA, Rojko JL, Stewart MA, Kociba GJ, Cheney CM, Rezanka LJ, Mathes LE, Hartke JR, Jarrett O, Neil JC.
    J Gen Virol; 1992 Nov 15; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.